Member Info for Rocket79

This has been posted before but a must watch if investors have not seen it yet. Http://www.youtube.com/watch?v=rURZCpO_Bn4

Tipped by Midas in the Times today also

Investors Chronicle have recommended Lookers a BUY

Looks like they may let this go back upto 130p over next couple of days as smart money buys in after good results and increase in divi.

Liberum has price target of 175p

Added on weakness as drop not warranted. Results were good expect these to rise from here

What a cracking set of results. I rate management here of the highest order.

I agree could see a 10% surge on results. Good luck

Sold some vtu and bought some Lookers LOOK as expected them to rise up to results next week. Hold both VTU and LOOK now

Trading going well especially aftermarket. This should be trading at 60p not in the 40's.

Angle raised funds at 64.50p a share last year. Since then Angle results have gone strength to strength with company transformational news due Q2. Anything under placing price is a bargain. Strong BUY imo

Excellent news

Expecting this to get closer to valuation over next 12 months

http://www.edisoninvestmentresearch.com/research/report/angle809878/preview/#js Angle’s H117 business update revealed that R&D activities are progressing well, while the company booked further research use sales. The first prospective clinical studies with Angle’s liquid biopsy system Parsortix in ovarian cancer reported positive early evaluation results and are due to report headline data in Q217. Our SOTP-based valuation is increased modestly to £140.3m or 188p/share. The main 2017 catalysts are the results from the ovarian cancer studies; an acceleration of research use sales; any new data from Angle’s multiple KOLs and customers investigating Parsortix; and progress with the FDA analytical and clinical studies

Yes I agree there should be one next week later. Possibly Monday morning. Good luck all

Hopefully not before I have bought enough shares to meet my target.

I'm with you and agree it's undervalued. Some quality well respected figures on the bod (ex Greegs). I am thinking they can turn this around.

Oversold as 17p a share is far too cheap. There are some headwinds but if you can see past them the future is very bright. I'm adding to my holding also. AL75 I have shared research on other companies in the past but after my last experience decided not to again and just keep it for myslef and close friends. Good luck

After doing some research this look like a good buy at this price and is oversold. Seems management are improving sales. First target price 30p. Dyor

"Yet, when we walk up the high street anywhere in the UK, we don’t feel their competitive position in the UK has changed at all. In fact, if anything, they’re now in a strong position.” According to data from Google Finance, the £1.7bn firm is trading on an 8x P/E ratio and has an EPS of 37p. https://m.trustnet.com/news/713336/the-ugly-uk-value-stocks-that-could-double-in-value